Incidence of additional genetic changes in the TEL and AML1 genes in DCOG and COALL-treated t(12;21)-positive pediatric ALL, and their relation with drug sensitivity and clinical outcome
Open Access
- 19 January 2006
- journal article
- Published by Springer Nature in Leukemia
- Vol. 20 (3), 410-416
- https://doi.org/10.1038/sj.leu.2404083
Abstract
No abstract availableKeywords
This publication has 38 references indexed in Scilit:
- Incidence and relevance of secondary chromosome abnormalities in childhood TEL/AML1+ acute lymphoblastic leukemia: an interphase FISH analysisLeukemia, 2004
- Sensitivity to L-asparaginase is not associated with expression levels of asparagine synthetase in t(12;21)+ pediatric ALLBlood, 2002
- BFM-oriented treatment for children with acute lymphoblastic leukemia without cranial irradiation and treatment reduction for standard risk patients: results of DCLSG protocol ALL-8 (1991–1996)Leukemia, 2002
- Minimal residual disease in leukaemia patientsThe Lancet Oncology, 2001
- Co-operative study group for childhood acute lymphoblastic leukemia (COALL): long-term follow-up of trials 82, 85, 89 and 92Leukemia, 2000
- Molecular genetics, natural history and the demise of childhood leukaemiaEuropean Journal Of Cancer, 1999
- The TEL gene products: nuclear phosphoproteins with DNA binding propertiesOncogene, 1997
- The der(21)t(12;21) chromosome is always formed in a 12;21 translocation associated with childhood acute lymphoblastic leukaemiaBritish Journal of Haematology, 1996
- Translocation of BCR to chromosome 9: A new cytogenetic variant detected by FISH in two Ph‐negative, BCR‐positive patients with chronic myeloid leukemiaGenes, Chromosomes and Cancer, 1993
- Nonparametric Estimation from Incomplete ObservationsJournal of the American Statistical Association, 1958